Second Affiliated Hospital of Xi'an Jiaotong University is the lead sponsor of 5 current clinical trials in our China register. 3 are recruiting patients now. The most common phase is Observational. The most-studied condition is Papillary Thyroid Cancer.
| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Screening for Early Gastric Cancer in Shaanxi Province
NCT05291728 · ClinicalTrials.gov ↗ · Early Gastric Cancer
|
Observational | Recruiting | 2020-10 | China |
|
A Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
NCT06791005 · ClinicalTrials.gov ↗ · Papillary Thyroid Cancer
|
Phase 3 | Recruiting | 2025-01 | China |
|
Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
NCT06286631 · ClinicalTrials.gov ↗ · Papillary Thyroid Cancer
|
Observational | Recruiting | 2023-05 | China |
|
Heated Humidified Oxygen in PACU Patients
NCT07778420 · ClinicalTrials.gov ↗ · Hypoxemia, Postoperative Complications, Anesthesia Recovery Period
|
Not applicable | Not yet open | 2026-09 | China |
|
Efficacy and Safety Evaluation of Microfocused Ultrasound Combined With 1550 nm Non-Ablative Fractional Laser for Facial Rejuvenation
NCT07107308 · ClinicalTrials.gov ↗ · Photo-aged Skin
|
Not applicable | Active, closed | 2024-11 | China |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in China | 5 | 3 |
A trial with sites in more than one country appears in each of those registers.
Second Affiliated Hospital of Xi'an Jiaotong University is the lead sponsor of 5 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 27 September 2026. Completed and withdrawn studies are not counted.
Yes. 3 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 27 Sep 2026.